3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
50
Paclitaxel
48
Cisplatin
39
Gemcitabine
31
Erlotinib Hydrochloride
30
Radiotherapy
28
Docetaxel
24
Taxes
21
Specimen Handling
20
Magnetic Resonance Spectroscopy
20
Vinorelbine
16
Pemetrexed
12
Etoposide
12
Bevacizumab
12
Radiation
10
Gefitinib
10
aldesleukin
8
Platinum
8
Bortezomib
8
Biopsy
8
Vinblastine
7
Azacitidine
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
6
atezolizumab
6
Observation
6
Immunoglobulin G
6
Disulfides
6
Cyclophosphamide
6
Chemotherapy, Adjuvant
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Carcinoma, Non-Small-Cell Lung
×
Tomography, Spiral Computed
×
Clear all
NCT00047385
2014-05-20
NLST
National Cancer Institute (NCI)
Phase 3
Completed
53,454 enrolled
15 charts